Showing results (11-20 of 610) with videos related to
Sort By:
Pageof 61
Psychopharmacology|July 21, 2014
Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosisJudith F Nottage, James Stone, Robin M Murray, et al.Journal of Psychopharmacology (Oxford, England)|November 1, 2017
The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid groupHarneet Hundal, Rachel Lister, Nicole Evans, et al.Journal of Psychopharmacology (Oxford, England)|October 15, 2015
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiencesElizabeth M Tunbridge, Graham Dunn, Robin M Murray, et al.Annual Review of Clinical Psychology|March 3, 2010
Substance use in adolescence and psychosis: clarifying the relationshipEmma Barkus, Robin M MurraySchizophrenia Bulletin|June 18, 2013
Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?Emre Bora, Robin M MurrayThe British Journal of Psychiatry. Supplement|September 26, 2002
Neurological soft signs in first-episode psychosis: a systematic reviewPaola Dazzan, Robin M MurrayDialogues in Clinical Neuroscience|August 3, 2005
Environmental risk factors for psychosisKimberlie Dean, Robin M MurrayExpert Review of Neurotherapeutics|April 28, 2005
Verbal memory deficit in patients with schizophrenia: an important future target for treatmentTimothea Toulopoulouand, Robin M MurrayJournal of Psychopharmacology (Oxford, England)|September 21, 2010
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET studyEmma Barkus, Paul D Morrison, D Vuletic, et al.Lancet (London, England)|December 10, 2013
Schizophrenia: an integrated sociodevelopmental-cognitive modelOliver D Howes, Robin M MurrayPageof 61